MEDvidi is a teletherapy provider that offers mental health treatment, including virtual therapy sessions, cognitive behavioral therapy, and prescription medications to treat mental health conditions. The company provides multimodal treatment plans (medication and therapy) specializing in mental conditions including ADHD, anxiety, depression, OCD, and insomnia.
Users begin by filling out a brief online form where MEDvidi's smart symptom checker asks questions to better understand the person's current state. They are then connected with a licensed therapist for personalized care. The therapist collaborates with the user to tailor a treatment plan that can include prescription management if needed. The platform employs measurement-based care to track patient progress.
MEDvidi operates a D2C model, charging users a fee for service. As of 1H 2023, the company’s services were available in 20 states, and it had plans to be available across all 50 states by 2026 as well as service 70,000 individuals monthly.
Funding and financials
In September 2022, MEDvidi Raised USD 2.8 million in a seed round.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.